Single-chain polymer nanoparticle and preparation method thereof
Crosslinked single-chain polymer nanoparticles prepared by using atomic transfer radical polymerization method in tumor tissues, the problem of traditional nanocarriers being difficult to penetrate deep tissues is solved, and the efficient targeted delivery of drugs is achieved, which significantly improves the therapeutic effect. .
Patent Information
- Application Number
- CN202411086081.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-08
- Publication Date
- 2024-11-22
AI Technical Summary
When traditional nanocarriers reach tumor tissue, it is difficult for them to penetrate deep tissue due to high-density extracellular matrix and fibrosis. Nanoparticles with particle size less than 10nm are easily excreted from the body, resulting in low targeted delivery efficiency and ineffective inhibition of tumor growth.
Preparation of amphiphilic block polymer folic acid-poly[oligoethylene glycol methyl ether methacrylate-b-(4-formylphenyl-methacrylate-co-methyl Diethylaminoethyl acrylate)], single-chain polymer nanoparticles are formed by cross-linking within the molecular chain, and are loaded with hydrophobic chemotherapy drugs, using an acidic microenvironment to transform the particle size to penetrate deep tumor tissue.
Targeted-deep delivery of anti-tumor drugs has been achieved, and the efficiency of drugs reaching deep tissues has been improved, which is of great significance to the treatment of cancer.
Smart Images

Figure FT_1 
Figure FT_2 
Figure SMS_1
Abstract
Description
Technical Field
[0001] The invention belongs to the field of nanomedicine and relates to a single-chain polymer nanoparticle and a preparation method thereof. Background Art
[0002] The tumor tissue structure is characterized by high extracellular matrix density and high degree of fibrosis (Solid stress inhibits the growth of multicellular tumor spheroids, Nat. Biotechnol. 1997,15:778-783). Nanocarriers need to overcome this barrier to reach deep tissues and release drugs at the therapeutic threshold to effectively inhibit tumor growth. However, the traditional nanocarrier delivery mode represented by liposomes, micelles, and dendrimers is single and inefficient, far from meeting the needs of clinical treatment: on the one hand, although nanoparticles with larger particle sizes can reach the tumor site through surface modification of targeting molecules or EPR effect, high-density extracellular matrix and high fibrosis inhibit them from reaching deep tissues. Particles with a particle size of less than 10 nm have the advantage of penetrating tissues, but they are easily excreted from the body through protein binding, metabolism, excretion and other steps before reaching the tumor site. Therefore, the ideal nanocarrier should recognize the difference between the in vivo environment and the tumor microenvironment and circulate in the body in the form of aggregates. After targeted enrichment to the lesion, the acidic microenvironment causes the particle size or surface charge to change, which is conducive to penetrating deep tumor tissues. Nanocarriers achieve targeted and deep delivery of anti-tumor drugs, which is of great significance for the treatment of cancer. Summary of the invention
[0003] The present invention aims to provide a single-chain polymer nanoparticle.
[0004] Another object of the present invention is to provide a method for preparing the above-mentioned single-chain polymer nanoparticles.
[0005] Another object of the present invention is to provide applications of the above-mentioned nanoparticles.
[0006] The object of the present invention is achieved by the following scheme: a single-chain polymer nanoparticle is formed by crosslinking an amphiphilic block polymer chain, an amphiphilic block polymer folic acid-poly[oligoethylene glycol methyl ether methacrylate- b -(4-Formylphenyl-methacrylate- co -diethylaminoethyl methacrylate)], its chemical structure is: Wherein, x, y, z are the degrees of polymerization.
[0007] The present invention provides a method for preparing single-chain polymer nanoparticles, which adopts atom transfer radical polymerization to prepare amphiphilic block polymer FA-POEGMA-bP (FPMA-co-DEA), and reacts with a crosslinking agent to form nanoparticles with intramolecular crosslinking, comprising the following steps: Step 1: Dissolve folic acid (FA) coupled single electron transfer initiator in N,N-dimethylformamide (DMF), add oligoethylene glycol methyl ether methacrylate (OEGMA) and ligand. Seal and fill with nitrogen, add copper wire, and react at room temperature for 24 h; Step 2: Monomers diethylaminoethyl methacrylate (DEA) and 4-formylphenyl-methacrylate (FPMA) were dissolved in DMF in proportion, deoxygenated, and injected into the reaction bottle of step 1, and reacted at room temperature for 48 h. The reaction was stopped by freezing with liquid nitrogen, purified by dialysis, and dried to obtain folic acid-poly[oligoethylene glycol methyl ether methacrylate- b -(4-Formylphenyl-methacrylate- co -diethylaminoethyl methacrylate)] FA-POEGMA- b -P(FPMA- co -DEA); Step 3: FA-POEGMA obtained in step 2 b -P(FPMA- co -DEA) was dissolved in DMF, a cross-linking agent was added, and the mixture was stirred for 24 h to form cross-linked single-chain polymer nanoparticles; Step 4: The cross-linked single-chain polymer in step 3 is dialyzed against deionized water to form single-chain polymer nanoparticle aggregates.
[0008] In step (1), the initiator is a folic acid (FA) coupled single electron transfer initiator, and the ligand is preferably tris[2-(dimethylamino)ethyl]amine. The molar ratio of the initiator to the ligand is preferably 2:1. The molar mass of OEGMA is preferably 300 g / mol. The molar ratio of the chain transfer agent to OEGMA is 1:10 to 50.
[0009] In steps (1) and (2), the molar ratio of OEGMA, FPMA and DEA is preferably 2:1:3.
[0010] In step (3), the cross-linking agent is preferably succinyl hydrazide. The molar ratio of the cross-linking agent to FPMA is preferably 1:2. In step (1), the preferred structure of folic acid (FA) coupled to a single electron transfer initiator is as follows: Preparation of amphiphilic block polymer FA-POEGMA- b -P(FPMA- co-DEA), reacts with a cross-linking agent to form nanoparticles with cross-linked molecules. The prepared single-chain polymer nanoparticles are loaded with hydrophobic chemotherapy drugs, circulate in vivo in the form of aggregates, and after targeted enrichment in tumors, the acidic microenvironment causes protonation and depolymerization, and the particle size changes, making it very easy to penetrate deep tumor tissues. Folic acid ligands accelerate the uptake of single-chain polymer nanoparticles by tumor cells. The single-chain polymer nanoparticles of the present invention achieve targeted-deep delivery of anti-tumor drugs, which is of great significance for the treatment of cancer. BRIEF DESCRIPTION OF THE DRAWINGS
[0011] Figure 1 is a transmission electron microscopy image of a single-chain polymer nanoparticle; Figure 2 Transmission electron microscopy image of single-chain polymer nanoparticle aggregates. DETAILED DESCRIPTION
[0012] The present invention will be further described below by way of examples, but the present invention is not limited to the examples given.
[0013] Example 1 A single-chain polymer nanoparticle is formed by crosslinking an amphiphilic block polymer chain, wherein the amphiphilic block polymer is folic acid-poly[oligoethylene glycol methyl ether methacrylate- b -(4-Formylphenyl-methacrylate- co -diethylaminoethyl methacrylate)], firstly prepare the amphiphilic block polymer FA-POEGMA-bP (FPMA-co-DEA) by atom transfer radical polymerization, and react with a crosslinking agent to form nanoparticles with intramolecular crosslinking, according to the following steps: Step 1: Dissolve 60 mg of folic acid (FA) coupled single electron transfer initiator in 2 mL of DMF, add 570 mg of OEGMA and 10.9 mg of ligand Me6-Tren, seal and fill with nitrogen, add 1 cm of copper wire, and react at room temperature for 24 h; Step 2: 527.2 mg DEA and 180.5 mg FPMA were dissolved in 2 mL DMF, deoxygenated and injected into the reaction bottle of step 1, and reacted at room temperature for 48 h; liquid nitrogen was used to freeze the reaction, and the product was purified by dialysis and dried to obtain FA-POEGMA- b -P(FPMA- co -DEA); Step 3: FA-POEGMA obtained in step 2 b -P(FPMA- co -DEA) was dissolved in 3 mL of DMF, 69.4 mg of cross-linking agent succinyl hydrazide was added, and the mixture was stirred for 24 h to form single-chain polymer nanoparticles with intrachain cross-linking. The transmission electron microscopy image of the single-chain polymer nanoparticles is shown in Figure 2.Figure 1 As shown; Step 4: The single-chain polymer nanoparticles in step 3 are dialyzed with deionized water to form single-chain polymer nanoparticle aggregates. The transmission electron microscopy image of the single-chain polymer nanoparticle aggregates is as follows: Figure 2 shown.
[0014] Example 2 A single-chain polymer nanoparticle is prepared in a similar manner to Example 1, except that the amounts of materials added in steps 1 to 3 are as shown in Table 1. The following steps are performed: Step 1: Dissolve 120 mg of folic acid (FA) coupled single electron transfer initiator in 2 mL of DMF, add 570 mg of OEGMA and 21.8 mg of ligand Me6-Tren, seal and fill with nitrogen, add 1 cm of copper wire, and react at room temperature for 24 h; Step 2: 527.2 mg DEA and 180.5 mg FPMA were dissolved in 2 mL DMF, deoxygenated and injected into the reaction bottle of step 1, and reacted at room temperature for 48 h; liquid nitrogen was used to freeze the reaction, and the product was purified by dialysis and dried to obtain FA-POEGMA- b -P(FPMA- co -DEA); Step 3: FA-POEGMA obtained in step 2 b -P(FPMA- co -DEA) was dissolved in 3 mL of DMF, 69.4 mg of cross-linking agent succinylhydrazide was added, and the mixture was stirred for 24 h to form single-chain polymer nanoparticles with intrachain cross-linking; Step 4: dialyze the single-chain polymer nanoparticles in step 3 against deionized water to form single-chain polymer nanoparticle aggregates.
[0015] Example 3 A single-chain polymer nanoparticle is prepared in a similar manner to Example 1, except that the amounts of materials added in steps 1 to 3 are as shown in Table 1. The following steps are performed: Step 1: Dissolve 60 mg of folic acid (FA) coupled single electron transfer initiator in 2 mL of DMF, add 855 mg of OEGMA and 10.9 mg of ligand Me6-Tren, seal and fill with nitrogen, add 1 cm of copper wire, and react at room temperature for 24 h; Step 2: 790.9 mg DEA and 270.8 mg FPMA were dissolved in 2 mL DMF, deoxygenated and injected into the reaction bottle of step 1, and reacted at room temperature for 48 h; liquid nitrogen was used to freeze the reaction, and the product was purified by dialysis and dried to obtain FA-POEGMA- b -P(FPMA- co -DEA); Step 3: FA-POEGMA obtained in step 2 b -P(FPMA- co -DEA) was dissolved in 3 mL of DMF, 104.1 mg of cross-linking agent succinylhydrazide was added, and the mixture was stirred for 24 h to form single-chain polymer nanoparticles with intrachain cross-linking; Step 4: dialyze the single-chain polymer nanoparticles in step 3 against deionized water to form single-chain polymer nanoparticle aggregates.
[0016] Example 4 A single-chain polymer nanoparticle is prepared in a similar manner to Example 1, except that the amounts of materials added in steps 1 to 3 are as shown in Table 1. The following steps are performed: Step 1: Dissolve 120 mg of folic acid (FA) coupled single electron transfer initiator in 2 mL DMF, add 2850 mg of OEGMA and 21.8 mg of ligand Me6-Tren, seal and fill with nitrogen, add 1 cm copper wire, and react at room temperature for 24 h; Step 2: 1581.8 mg DEA and 541.5 mg FPMA were dissolved in 2 mL DMF, deoxygenated and injected into the reaction bottle of step 1, and reacted at room temperature for 48 h; liquid nitrogen was used to freeze the reaction, and the product was purified by dialysis and dried to obtain FA-POEGMA- b -P(FPMA- co -DEA); Step 3: FA-POEGMA obtained in step 2 b -P(FPMA- co -DEA) was dissolved in 3 mL of DMF, 208.3 mg of cross-linking agent succinylhydrazide was added, and the mixture was stirred for 24 h to form single-chain polymer nanoparticles with intrachain cross-linking; Step 4: dialyze the single-chain polymer nanoparticles in step 3 against deionized water to form single-chain polymer nanoparticle aggregates.
[0017] Example 5 A single-chain polymer nanoparticle is prepared in a similar manner to Example 1, except that the amount of materials added in steps 1 to 3 is as shown in Table 2. The following steps are performed: Step 1: Dissolve 150 mg of folic acid (FA) coupled single electron transfer initiator in 2 mL of DMF, add 3206.2 mg of OEGMA and 27.2 mg of ligand Me6-Tren, seal and fill with nitrogen, add 1 cm of copper wire, and react at room temperature for 24 h; Step 2: 1779.5 mg DEA and 609.2 mg FPMA were dissolved in 2 mL DMF, deoxygenated and injected into the reaction bottle of step 1, and reacted at room temperature for 48 h; liquid nitrogen was used to freeze the reaction, and the product was purified by dialysis and dried to obtain FA-POEGMA- b -P(FPMA- co -DEA); Step 3: FA-POEGMA obtained in step 2 b -P(FPMA- co -DEA) was dissolved in 3 mL of DMF, 234.3 mg of cross-linking agent succinylhydrazide was added, and the mixture was stirred for 24 h to form single-chain polymer nanoparticles with intrachain cross-linking; Step 4: dialyze the single-chain polymer nanoparticles in step 3 against deionized water to form single-chain polymer nanoparticle aggregates.
[0018] Example 6 A single-chain polymer nanoparticle is prepared in a similar manner to Example 1, except that the amounts of materials added in steps 1 to 3 are as shown in Table 1. The following steps are performed: Step 1: Dissolve 180 mg of folic acid (FA) coupled single electron transfer initiator in 2 mL of DMF, add 1282.5 mg of OEGMA and 32.6 mg of ligand Me6-Tren, seal and fill with nitrogen, add 1 cm of copper wire, and react at room temperature for 24 h; Step 2: 711.8 mg DEA and 243.7 mg FPMA were dissolved in 2 mL DMF, deoxygenated and injected into the reaction bottle of step 1, and reacted at room temperature for 48 h; liquid nitrogen was used to freeze the reaction, and the product was purified by dialysis and dried to obtain FA-POEGMA- b -P(FPMA- co -DEA); Step 3: FA-POEGMA obtained in step 2 b -P(FPMA- co -DEA) was dissolved in 3 mL of DMF, 93.7 mg of cross-linking agent succinylhydrazide was added, and the mixture was stirred for 24 h to form single-chain polymer nanoparticles with intrachain cross-linking; Step 4: dialyze the single-chain polymer nanoparticles in step 3 against deionized water to form single-chain polymer nanoparticle aggregates.
[0019] Example 7 A single-chain polymer nanoparticle is prepared in a similar manner to Example 1, except that the amounts of materials added in steps 1 to 3 are as shown in Table 1. The following steps are performed: Step 1: Dissolve 200 mg of folic acid (FA) coupled single electron transfer initiator in 2 mL of DMF, add 2375 mg of OEGMA and 36.2 mg of ligand Me6-Tren, seal and fill with nitrogen, add 1 cm of copper wire, and react at room temperature for 24 h; Step 2: 1318.1 mg DEA and 451.3 mg FPMA were dissolved in 2 mL DMF, deoxygenated and injected into the reaction bottle of step 1, and reacted at room temperature for 48 h; liquid nitrogen was used to freeze the reaction, and the product was purified by dialysis and dried to obtain FA-POEGMA- b -P(FPMA- co -DEA); Step 3: FA-POEGMA obtained in step 2 b -P(FPMA- co -DEA) was dissolved in 3 mL of DMF, 173.5 mg of cross-linking agent succinylhydrazide was added, and the mixture was stirred for 24 h to form single-chain polymer nanoparticles with intrachain cross-linking; Step 4: dialyze the single-chain polymer nanoparticles in step 3 against deionized water to form single-chain polymer nanoparticle aggregates.
[0020] Table 1 shows the amount of materials added in steps 1 to 3: .
Claims
1. A single-chain polymer nanoparticle, characterized in that: It is formed by cross-linking in the chain of amphiphilic block polymer, wherein the amphiphilic block polymer is folic acid-poly[oligoethylene glycol methyl ether methacrylate- b -(4-Formylphenyl-methacrylate- co -diethylaminoethyl methacrylate)], its chemical structure is: Wherein, x, y, z are the degrees of polymerization.
2. The method for preparing single-chain polymer nanoparticles according to claim 1, characterized in that: The amphiphilic block polymer is first prepared by atom transfer radical polymerization to form amphiphilic block polymer FA-POEGMA-bP (FPMA-co-DEA), which is then reacted with a crosslinking agent to form nanoparticles with intramolecular crosslinking, comprising the following steps: Step 1: Dissolve folic acid (FA) coupled single electron transfer initiator in N,N-dimethylformamide (DMF), add oligoethylene glycol methyl ether methacrylate (OEGMA) and ligand, seal and fill with nitrogen, add copper wire, and react at room temperature for 24 h; Step 2: Monomers diethylaminoethyl methacrylate (DEA) and 4-formylphenyl-methacrylate (FPMA) were dissolved in DMF in proportion, injected into the reaction solution of step 1 after deoxygenation, and reacted at room temperature for 48 h; the reaction was stopped by freezing with liquid nitrogen, purified by dialysis, and dried to obtain folic acid-poly[oligoethylene glycol methyl ether methacrylate- b -(4-Formylphenyl-methacrylate- co -diethylaminoethyl methacrylate)], namely FA-POEGMA- b -P(FPMA- co -DEA); Step 3: FA-POEGMA obtained in step 2 b -P(FPMA- co -DEA) was dissolved in DMF, a cross-linking agent was added, and the mixture was stirred for 24 h to form single-chain polymer nanoparticles with intrachain cross-linking; Step 4: dialyze the single-chain polymer nanoparticles in step 3 against deionized water to form single-chain polymer nanoparticle aggregates.
3. The method for preparing single-chain polymer nanoparticles according to claim 2, characterized in that: The ligand in step (1) is preferably tri[2-(dimethylamino)ethyl]amine, and the preferred molar ratio of folic acid (FA) coupled single electron transfer initiator and ligand is 2:1; the preferred molar mass of OEGMA is 300 g / mol; and the molar ratio of chain transfer initiator to OEGMA is 1:10-50.
4. The method for preparing single-chain polymer nanoparticles according to claim 2, characterized in that In steps (1) and (2), the preferred molar ratio of OEGMA, FPMA and DEA is 2:1:
3.
5. The method for preparing single-chain polymer nanoparticles according to claim 2, characterized in that In step (3), the cross-linking agent is preferably succinylhydrazide; the molar ratio of the cross-linking agent to FPMA is 1:
2.
6. The method for preparing single-chain polymer nanoparticles according to claims 2 to 5, characterized in that: Steps 1 to 3 are to add materials according to the following table: 。 7. Use of the single-chain polymer nanoparticles according to claim 1 in drug delivery.
